Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Quercetin reduce cardiomyocytes damage in type 2 diabetic rats

Universa Medicina · Vol. 33 No. 3 (2014) · hlm. 185–191

DOI
10.18051/UnivMed.2014.v33.185-191
ISSN
2407-2230, 1907-3062
Terbit
2014-12-02
Penerbit
Faculty of Medicine, Universitas Trisakti
Bahasa
eng

Abstrak

BACKGROUNDDiabetes mellitus (DM) is a group of metabolic diseases which are characterized by hyperglycemia, resulting in various complications. A major macrovascular complication of DM is cardiac failure due to cardiomyopathy. Hyperglycemiaincreases oxidative stress, so an oxidative-stress reducing therapeutic agent is required, e.g. the antioxidant quercetin. The aim of this study was to assess the effects of quercetin in reducing damage to cardiomyocytes of type 2 diabetic rats.METHODSThis research is an experimental study using 40 rats. With simple randomallocation, rats were divided into eight groups, then type 2 diabetes mellituswas induced using streptozotocin (5 rats per group). The test material wasquercetin given at doses of 5, 20 and 80 mg/kgBW/day orally for 4 weeks.Each single dose of quercetin was given in combination with glibenclamide 5mg/ kgBW/day. After 4 weeks the rats were decapitated and the cardiac tissuestaken to quantify the percentage of cell damage after hematoxylin-eosin staining(HE).RESULTSQuercetin at a dose of 80 mg/kgBW/day can lower cardiomyocyte damagebetter than quercetin at doses of 5 or 20 mg/kgBW/day. A combination ofquercetin and glibenclamide can significantly lower levels of cardiomyocytedamage better than quercetin without glibenclamide (p<0.05).CONCLUSIONQuercetin at a dose of 80 mg/kgBW/day with or without glibenclamide canlower damage to cardiomyocytes of type 2 diabetic rats. Thus quercetin mightserve as a valuable protective agent in cardiovascular inflammatory diseasesin diabetic rats.

Kata kunci

Jaringan kolaborasi para penulis

2 penulis · 1 tautan kepenulisan bersama · 1 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Islamic University of Indonesia
  • Universitas Gadjah Mada
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://univmed.org/ejurnal/index.php/medicina/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Quercetin reduce cardiomyocytes damage in type 2 diabetic rats</dc:title>
	<dc:creator xml:lang="en">Hendrawati, Asri</dc:creator>
	<dc:creator xml:lang="en">Nadhir, Nadhir</dc:creator>
	<dc:subject xml:lang="en">Quercetin</dc:subject>
	<dc:subject xml:lang="en">glibenclamide</dc:subject>
	<dc:subject xml:lang="en">cardiomyocytes</dc:subject>
	<dc:subject xml:lang="en">type 2 diabetes mellitus</dc:subject>
	<dc:subject xml:lang="en">rats</dc:subject>
	<dc:description xml:lang="en">BACKGROUNDDiabetes mellitus (DM) is a group of metabolic diseases which are characterized by hyperglycemia, resulting in various complications. A major macrovascular complication of DM is cardiac failure due to cardiomyopathy. Hyperglycemiaincreases oxidative stress, so an oxidative-stress reducing therapeutic agent is required, e.g. the antioxidant quercetin. The aim of this study was to assess the effects of quercetin in reducing damage to cardiomyocytes of type 2 diabetic rats.METHODSThis research is an experimental study using 40 rats. With simple randomallocation, rats were divided into eight groups, then type 2 diabetes mellituswas induced using streptozotocin (5 rats per group). The test material wasquercetin given at doses of 5, 20 and 80 mg/kgBW/day orally for 4 weeks.Each single dose of quercetin was given in combination with glibenclamide 5mg/ kgBW/day. After 4 weeks the rats were decapitated and the cardiac tissuestaken to quantify the percentage of cell damage after hematoxylin-eosin staining(HE).RESULTSQuercetin at a dose of 80 mg/kgBW/day can lower cardiomyocyte damagebetter than quercetin at doses of 5 or 20 mg/kgBW/day. A combination ofquercetin and glibenclamide can significantly lower levels of cardiomyocytedamage better than quercetin without glibenclamide (p&amp;lt;0.05).CONCLUSIONQuercetin at a dose of 80 mg/kgBW/day with or without glibenclamide canlower damage to cardiomyocytes of type 2 diabetic rats. Thus quercetin mightserve as a valuable protective agent in cardiovascular inflammatory diseasesin diabetic rats.</dc:description>
	<dc:publisher xml:lang="en">Faculty of Medicine, Universitas Trisakti</dc:publisher>
	<dc:date>2014-12-02</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://univmed.org/ejurnal/index.php/medicina/article/view/20</dc:identifier>
	<dc:identifier>10.18051/UnivMed.2014.v33.185-191</dc:identifier>
	<dc:source xml:lang="en">Universa Medicina; Vol. 33 No. 3 (2014); 185-191</dc:source>
	<dc:source>2407-2230</dc:source>
	<dc:source>1907-3062</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://univmed.org/ejurnal/index.php/medicina/article/view/20/15</dc:relation>
	<dc:relation>10.18051/univmed.v33i3.20</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2014 Asri Hendrawati, Nadhir Nadhir</dc:rights>
</oai_dc:dc>